SEK 30.48
Key Takeaways
Risk factor
Vulnerable to price shocks
Profitability factor
Greatly undervalued vs peers
About
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema,...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalue
Target Price
The average target price of ARJO-B.ST is 39 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
